Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hernández, E.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández, E.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 6, 1417-1418, June 1999
© 1999 European Society of Human Reproduction and Embryology

Debate

The good, the bad and the ugly

E.R. Hernández

Centro de Reproduccion Asistida FIV-Madrid, Alvarez de Baena 4, Madrid, Spain and Instituto de Bioquimica, CSIC, Madrid, Spain

After recently spending 2 days listening to a group of very distinguished professors and scientists with many years of experience in ovulation induction, and having read the recent debate on Puregon (Meniru, 1999Go), it seems to me that the ovulation induction market resembles a spaghetti western; the film `The Good, the Bad and the Ugly' comes particularly to mind, with the characters in our version being recombinant follicle stimulating hormone (FSH) as the good guy, urinary FSH as the ugly one and clomiphene citrate as the bad guy. Just as in the original movie, the good guy and the ugly guy join . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?